The following article has some great information on the wound care market:
http://www.med-techinnovation.com/Articles/articles/article/15
Some key points are:
Espicom believes KCI held 27% of the [wound care] market in 2009, Smith & Nephew 16.5%, ConvaTec 10%, M?lnlycke 9%, and both Systagenix and Coloplast 6%, and 25% was held by smaller and privately held companies.
The International Diabetes Federation estimates that there were 285 million people with diabetes globally in 2009 and that the total number will exceed 435 million in 2030 if current rates of growth continue unchecked. Developed world studies have estimated that 15% of people with diabetes will ultimately have diabetic foot ulcers.
A review by Kaltenthaler and colleagues in 2001 found the rates of pressure ulcers in the community in the UK vary between 4.4 and 6.8%
It has been estimated that more than 600,000 people are treated for venous leg ulcers each year in the US. However, this number is likely to be an underestimation of the true prevalence of venous ulceration because many patients fail to seek medical care. Estimates range from 1 to 2% of populations studied.
The following article has some great information on the wound...
Add to My Watchlist
What is My Watchlist?